Front Month Nymex ULSD Rose 3.70% This Week to Settle at $2.1615 — Data Talk
Front Month Nymex ULSD for Oct. delivery gained 7.72 cents per gallon, or 3.70% to $2.1615 this week
--Largest one week net and percentage gain since the week ending June 14, 2024
--Snaps a five week losing streak
--Today it is down 1.05 cents or 0.48%
--Largest one day dollar and percentage decline since Friday, Sept. 13, 2024
--Snaps a four session winning streak
--Off 35.71% from its 52-week high of $3.3622 hit Friday, Sept. 29, 2023
--Up 5.03% from its 52-week low of $2.058 hit Tuesday, Sept. 10, 2024
--Down 34.62% from 52 weeks ago
--Off 27.08% from its 2024 settlement high of $2.9642 hit Friday, Feb. 9, 2024
--Up 5.03% from its 2024 settlement low of $2.058 hit Tuesday, Sept. 10, 2024
--Off 57.91% from its record high of $5.1354 hit Thursday, April 28, 2022
--Month-to-date it is down 4.00%
--Year-to-date it is down 39.16 cents or 15.34%
All prices are calculated based on the settlement price of the current front month contract.
Source: Dow Jones Market Data
(END) Dow Jones Newswires
September 20, 2024 15:02 ET (19:02 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk